Stay updated on Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page.

Latest updates to the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check17 days agoChange DetectedA site-wide NIH notice was added, directing visitors to transition updates and explaining that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.7%

- Check24 days agoChange DetectedThe ClinicalTrials.gov site revision identifier was updated from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check31 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry, Revision: v3.7.0, was added to the study record history, and the previous revision, Revision: v3.6.6, was removed from the visible history.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision entry v3.6.6 appears in the study history, replacing the previous v3.6.5, indicating a small update to the page’s revision record.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page.